InsiderClue
Insiders · Profile

Lucas Svetlana

Chief Business Officer at Scribe Therapeutics · Director at Jasper Therapeutics. Filing since 22 Sep 2025. CIK 0001781292

SCTX Scribe Therapeutics, Inc. Chief Business Officer · 1 trade JSPR Jasper Therapeutics, Inc. Director · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
SCTX Scribe Therapeutics, Inc.
23 Jul 2026
Chief Business Officer
Bought
3,000
$45.00K
opened
JSPR Jasper Therapeutics, Inc.
22 Sep 2025
Director
Bought
20,000
$48.60K
opened
2 decisions on file.